Abstract
Background:It has been suggested that perioperative use of biological disease-modifying anti-rheumatic drugs (bDMARDs) in rheumatoid arthritis (RA) patients carries risks for the surgical-site infection and the delayed wound healing (DWH);...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have